Basic Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Jun 21, 2023; 29(23): 3622-3644
Published online Jun 21, 2023. doi: 10.3748/wjg.v29.i23.3622
Figure 11
Figure 11  Diagram of the mechanism of 18β-glycyrrhetinic acid therapy for gastric cancer cells. 18β-GRA: 18β-glycyrrhetinic acid; mTOR: Mammalian target of rapamycin; Bcl-2: B-cell lymphoma 2; NBR1: Neighbor of BRCA1 gene 1; PE: Phosphatidylethanolamine.